Generative artificial intelligence (AI) is now widely applied in medicinal chemistry, with detailed case studies emerging in the literature. Here, we describe an early application of REINVENT, AstraZeneca's in-house generative molecular design platform, to identify new inhibitor scaffolds for hematopoietic progenitor kinase 1 (HPK1). REINVENT was deployed at two stages of the project to address distinct design objectives. For hit identification, transfer learning on kinase-active compounds, followed by reinforcement learning guided by QSAR-based scoring, led to the discovery of three active chemotypes. Subsequently, REINVENT was applied to scaffold hopping, using 3D pharmacophore and docking models as scoring functions, which enabled the identification of two additional active chemotypes. Optimization of one of these scaffolds delivered a compound with potent cellular activity, kinase selectivity, and favorable rat pharmacokinetics. These results demonstrate the value of integrating generative AI with medicinal chemistry expertise and support broader application of the approach in future discovery programs.
K. Giblin, Kun Song, Hongming Chen et al.· Journal of Medicinal Chemist...· 0 citations
Infrared (IR) spectra provide characteristic signals of molecular structure, which are often interpreted by experts via functional-group identification or library matching, making the process time-consuming and ambiguous. Recent machine learning methods have made progress in molecular structure elucidation using molecular formulas and IR spectra. However, these models often infer unreasonable candidate molecular structures, including top-ranked predictions. More specifically, the molecular formula implied by a candidate structure often fails to match the input molecular formula, and the candidate's theoretical IR spectrum is often inconsistent with the observed IR spectrum. To address these issues, we propose Formula- and IR-Matched Preference Optimization (FIRMPO), a general and plug-and-play chemical feedback-driven preference optimization framework for molecular structure elucidation. FIRMPO incorporates chemical feedback as preference signals based on exact molecular formula matching and IR spectral consistency to guide reasonable structure predictions. Unlike generic preference optimization methods, FIRMPO is tailored to molecular structure elucidation while remaining model-agnostic, enabling it to be readily integrated with different structure prediction models in this class. This encourages models to prioritize structures that satisfy the chemical feedback, leading to a substantial improvement in the accuracy of top-ranked predictions. Extensive experiments on three widely used IR datasets show that FIRMPO significantly improves molecular structure elucidation accuracy over existing baselines.
Yusen Tan, Hongyu Zhan, Hai-tao Yu et al.· 0 citations
